Invitae Corporation (NYSE: NVTA), a genetic information company, has announced that it has more than doubled the size of its genetic testing platform to include more than 600 genes and will begin ...
Horizon Therapeutics plc in partnership with Invitae Corporation announced a new urea cycle disorder (UCD) genetic testing programme designed to speed diagnosis and enable physicians to offer genetic ...
A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers – a significant increase over just a few years ago. Previous research found that in 2010 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results